Stepping into their shoes: EU-ProPER studies partners of PCa patients
November 8, 2024Read moreWhat is the extent of the physical and psychological burdens that prostate cancer (PCa) imposes on the partners of...
00
Pathology: Is AI progressing in clinical application?
November 7, 2024Read moreIn the European Society of Uropathology Symposium (ESUP) on Day 1 of EMUC24, expert speakers delivered updates on the...
Current evidence in PCa screening
November 7, 2024Read moreThe inaugural session of the EAU Section of Urological Imaging programme, Plenary Session 1 “Prostate cancer screening” provided the...
Integrating AI for PCa screening and diagnosis: ProCancer-I
November 7, 2024Read moreDuring the first session by the EAU Section on Urological Imaging on Day 1 at EMUC24 in Lisbon, biomedical...
EMUC24 preview: Pathology and imaging advancements, soft skills, and global health inequalities
September 26, 2024Read moreThe upcoming 16th European Multidisciplinary Congress on Urological Cancers (Lisbon, Portugal from 7-10 November) is a key learning platform...
A new collaboration with the Kidney Cancer Association
September 3, 2024Read moreThis year, the 16th European Multidisciplinary Congress on Urological Cancers (EMUC24) will feature two plenary sessions designed by the...
Cross-disciplines and AI in focus at EMUC24: An advance look at what awaits you at the congress
July 3, 2024Read moreThe progress of major trials, the advent of artificial intelligence (AI), and interdisciplinary best practices will comprise the scientific...
RCC: Molecular imaging techniques? Delayed nephrectomy?
November 6, 2023Read moreIndividualised approaches to kidney cancer were deliberated in Plenary Session 12 on the afternoon of day three at EMUC23....
mCRPC: Insights on Lu-PSMA, PARP inhibitors, and new targeted approaches
November 5, 2023Read moreThe second half of Plenary Session 13 “New standards and novel approaches in advanced prostate cancer” was spearheaded by...
